{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:41:53Z","timestamp":1790800913716,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with adrenal insufficiency (AI) are treated with glucocorticoid replacement therapy (GRT). Although current glucocorticoid regimens aim to mimic the physiological circadian rhythm of cortisol secretion, temporary phases of hypo- and hypercortisolism are common undesired effects which lead to a variety of consequences like increased cardiovascular risk and premature mortality. Additionally, poor quality of life (QoL) and impaired sleep have been reported. However, little is known about these topics regarding the effects of daily dosage, duration of therapy, and patients with different forms of AI (primary, PAI, and secondary, SAI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, 40 adults with AI substituted with hydrocortisone (HC) and 20 matched healthy controls completed questionnaires evaluating depressive symptoms, subjective health status, quality of sleep and daytime sleepiness. Furthermore, demographic data, dosage of HC, duration of therapy and co-medication were evaluated. Patients were compared in different groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients assessed general health significantly worse than controls; likewise, daytime sleepiness was reported significantly more often. Depressive symptoms differed significantly in the two groups but did not reach clinically relevant scores. There was no difference between patients with PAI and SAI. High dosage of hydrocortisone had negative impact on mental health but not on sleep quality or daytime sleepiness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present data highlight that poor QoL and impaired sleep are still severe and underrated issues in current GRT and might be additional factors for premature mortality in patients with AI. Some AI patients reach normal or near-normal self-assessed QoL and sleep, even despite unphysiological replacement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-021-02731-y","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T22:02:32Z","timestamp":1628892152000},"page":"1653-1658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Poor quality of life and sleep in patients with adrenal insufficiency\u2014another cause of increased mortality?"],"prefix":"10.1007","volume":"191","author":[{"given":"Antje K.","family":"Blacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir H.","family":"Rahvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"van de Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-0769","authenticated-orcid":false,"given":"Birgit","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"2731_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101:364\u2013389. https:\/\/doi.org\/10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR2","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N et al (2016) Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101:3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/2042018810380214","volume":"1","author":"S Chan","year":"2010","unstructured":"Chan S, Debono M (2010) Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. Ther Adv Endocrinol Metab 1:129\u2013138. https:\/\/doi.org\/10.1177\/2042018810380214","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2731_CR4","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M et al (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954\u20133961. https:\/\/doi.org\/10.1210\/jc.2006-0524","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR5","doi-asserted-by":"publisher","first-page":"3691913","DOI":"10.1155\/2017\/3691913","volume":"2017","author":"AH Rahvar","year":"2017","unstructured":"Rahvar AH, Haas CS, Danneberg S et al (2017) Increased cardiovascular risk in patients with adrenal insufficiency: a short review. Biomed Res Int 2017:3691913. https:\/\/doi.org\/10.1155\/2017\/3691913","journal-title":"Biomed Res Int"},{"key":"2731_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/EJE-08-0550","volume":"160","author":"MM Erichsen","year":"2009","unstructured":"Erichsen MM, L\u00f8v\u00e5s K, Fougner KJ et al (2009) Normal overall mortality rate in Addison\u2019s disease, but young patients are at risk of premature death. Eur J Endocrinol 160:233\u2013237. https:\/\/doi.org\/10.1530\/EJE-08-0550","journal-title":"Eur J Endocrinol"},{"key":"2731_CR7","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"Falhammar H, Fris\u00e9n L, Norrby C et al (2014) Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 99:E2715\u2013E2721. https:\/\/doi.org\/10.1210\/jc.2014-2957","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108788","volume":"167","author":"AK Blacha","year":"2021","unstructured":"Blacha AK, Rahvar AH, Flitsch J et al (2021) Impaired attention in patients with adrenal insufficiency \u2013 impact of unphysiological therapy. Steroids 167:108788. https:\/\/doi.org\/10.1016\/j.steroids.2020.108788","journal-title":"Steroids"},{"key":"2731_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11011-014-9511-x","volume":"29","author":"M Henry","year":"2014","unstructured":"Henry M, Thomas KGF (2014) Episodic memory impairment in Addison\u2019s disease: results from a telephonic cognitive assessment. Metab Brain Dis 29:421\u2013430. https:\/\/doi.org\/10.1007\/s11011-014-9511-x","journal-title":"Metab Brain Dis"},{"key":"2731_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.01.025","volume":"55","author":"K Schultebraucks","year":"2015","unstructured":"Schultebraucks K, Wingenfeld K, Heimes J et al (2015) Cognitive function in patients with primary adrenal insufficiency (Addison\u2019s disease). Psychoneuroendocrinology 55:1\u20137. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.01.025","journal-title":"Psychoneuroendocrinology"},{"key":"2731_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1530\/EJE-12-0351","volume":"167","author":"S Benson","year":"2012","unstructured":"Benson S, Neumann P, Unger N et al (2012) Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency. Eur J Endocrinol 167:679\u2013685. https:\/\/doi.org\/10.1530\/EJE-12-0351","journal-title":"Eur J Endocrinol"},{"key":"2731_CR12","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1210\/jcem.85.11.6965","volume":"85","author":"D Garc\u00cda-Borreguero","year":"2000","unstructured":"Garc\u00cda-Borreguero D, Wehr TA, Larrosa O et al (2000) Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J Clin Endocrinol Metab 85:4201\u20134206. https:\/\/doi.org\/10.1210\/jcem.85.11.6965","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1530\/EJE-18-0439","volume":"179","author":"M Henry","year":"2018","unstructured":"Henry M, Ross I, Thomas KGF (2018) Reduced slow-wave sleep and altered diurnal cortisol rhythms in patients with Addison\u2019s disease. Eur J Endocrinol 179:319\u2013330. https:\/\/doi.org\/10.1530\/EJE-18-0439","journal-title":"Eur J Endocrinol"},{"key":"2731_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.physbeh.2015.08.011","volume":"151","author":"M Henry","year":"2015","unstructured":"Henry M, Wolf PSA, Ross IL et al (2015) Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison\u2019s disease. Physiol Behav 151:379\u2013385. https:\/\/doi.org\/10.1016\/j.physbeh.2015.08.011","journal-title":"Physiol Behav"},{"key":"2731_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/EJE-14-0023","volume":"171","author":"J Tiemensma","year":"2014","unstructured":"Tiemensma J, Andela CD, Kaptein AA et al (2014) Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature. Eur J Endocrinol 171:171\u2013182. https:\/\/doi.org\/10.1530\/EJE-14-0023","journal-title":"Eur J Endocrinol"},{"key":"2731_CR16","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1210\/jc.2009-0672","volume":"94","author":"AA Alkatib","year":"2009","unstructured":"Alkatib AA, Cosma M, Elamin MB et al (2009) A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab 94:3676\u20133681. https:\/\/doi.org\/10.1210\/jc.2009-0672","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR17","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.85.12.4650","volume":"85","author":"PJ Hunt","year":"2000","unstructured":"Hunt PJ, Gurnell EM, Huppert FA et al (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison\u2019s disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650\u20134656. https:\/\/doi.org\/10.1210\/jc.85.12.4650","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","volume":"97","author":"G Johannsson","year":"2012","unstructured":"Johannsson G, Nilsson AG, Bergthorsdottir P et al (2012) Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency\u202f: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 97:473\u2013481. https:\/\/doi.org\/10.1210\/jc.2011-1926","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12020-020-02552-6","volume":"72","author":"C Krekeler","year":"2021","unstructured":"Krekeler C, Kropp P, Blacha AK et al (2021) Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep. Endocrine 72:223\u2013233. https:\/\/doi.org\/10.1007\/s12020-020-02552-6","journal-title":"Endocrine"},{"key":"2731_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004","journal-title":"Arch Gen Psychiatry"},{"key":"2731_CR21","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware Jr","year":"2000","unstructured":"Ware JE Jr (2000) SF-36 health survey update. Spine 25:3130\u20133139","journal-title":"Spine"},{"key":"2731_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1210\/jc.2009-1711","volume":"95","author":"K L\u00f8v\u00e5s","year":"2010","unstructured":"L\u00f8v\u00e5s K, Curran S, Oksnes M et al (2010) Development of a disease-specific quality of life questionnaire in Addison\u2019s disease. J Clin Endocrinol Metab 95:545\u2013551. https:\/\/doi.org\/10.1210\/jc.2009-1711","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysee","year":"1989","unstructured":"Buysee DJ, Reynolds CF 3rd, Monk TH et al (1989) The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4","journal-title":"Psychiatry Res"},{"key":"2731_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540\u2013545. https:\/\/doi.org\/10.1093\/sleep\/14.6.540","journal-title":"Sleep"},{"key":"2731_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"Beck AT, Steer RA, Garbin MGJ (1988) Psychometric properties of the Beck Depression Inventory. Twenty- five years of evaluation. Clin Psychol Rev 8:77\u2013100. https:\/\/doi.org\/10.1016\/0272-7358(88)90050-5","journal-title":"Clin Psychol Rev"},{"key":"2731_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1210\/jc.2011-1901","volume":"97","author":"M Oksnes","year":"2012","unstructured":"Oksnes M, Bensing S, Hulting AL et al (2012) Quality of life in European patients with Addison\u00b4s disease: validity of the disease specific questionnaire AddiQoL. J Clin Endocrinol Metab 97:568\u2013576. https:\/\/doi.org\/10.1210\/jc.2011-1901","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10484-009-9082-5","volume":"34","author":"B Harbeck","year":"2009","unstructured":"Harbeck B, Kropp P, M\u00f6nig H (2009) Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study. Appl Psychophysiol Biofeedback 34:113\u2013119. https:\/\/doi.org\/10.1007\/s10484-009-9082-5","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"2731_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jsmc.2017.01.005","volume":"12","author":"MS Khan","year":"2017","unstructured":"Khan MS, Aouad R (2017) The effects of insomnia and sleep loss on cardiovascular disease. Sleep Med Clin 12:167\u2013177. https:\/\/doi.org\/10.1016\/j.jsmc.2017.01.005","journal-title":"Sleep Med Clin"},{"key":"2731_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1503\/cmaj.111589","volume":"184","author":"I Narang","year":"2012","unstructured":"Narang I, Manlhiot C, Davies-Shaw J et al (2012) Sleep disturbance and cardiovascular risk in adolescents. CMAJ 184:913\u2013920. https:\/\/doi.org\/10.1503\/cmaj.111589","journal-title":"CMAJ"},{"key":"2731_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.sleep.2019.04.015","volume":"61","author":"H Dai","year":"2019","unstructured":"Dai H, Mei Z, An A et al (2019) Association between sleep problems and health-related quality of life in Canadian adults with chronic diseases. Sleep Med 61:26\u201330. https:\/\/doi.org\/10.1016\/j.sleep.2019.04.015","journal-title":"Sleep Med"},{"key":"2731_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/aur.2103","volume":"12","author":"MK Deserno","year":"2019","unstructured":"Deserno MK, Borsboom D, Begeer S et al (2019) Sleep determines quality of life in autistic adults: a longitudinal study. Autism Res 12:794\u2013801. https:\/\/doi.org\/10.1002\/aur.2103","journal-title":"Autism Res"},{"key":"2731_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1210\/jcem-58-3-410","volume":"58","author":"HL Fehm","year":"1984","unstructured":"Fehm HL, Klein E, Holl R et al (1984) Evidence for extrapituitary mechanisms mediating the morning peak of plasma cortisol in man. J Clin Endocrinol Metab 58:410\u2013414. https:\/\/doi.org\/10.1210\/jcem-58-3-410","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1176\/jnp.2006.18.4.450","volume":"18","author":"RE Anglin","year":"2006","unstructured":"Anglin RE, Rosebush PI, Mazurek MF (2006) The neuropsychiatric profile of Addison\u2019s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci 18:450\u2013459. https:\/\/doi.org\/10.1176\/jnp.2006.18.4.450","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2731_CR34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.psyneuen.2006.01.003","volume":"31","author":"AF Thomsen","year":"2006","unstructured":"Thomsen AF, Kvist TK, Andersen PK et al (2006) The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology 31:614\u2013622. https:\/\/doi.org\/10.1016\/j.psyneuen.2006.01.003","journal-title":"Psychoneuroendocrinology"},{"key":"2731_CR35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1530\/EC-17-0295","volume":"6","author":"L Ferreira","year":"2017","unstructured":"Ferreira L, Silva J, Garrido S et al (2017) Primary adrenal insufficiency in adult population: a Portuguese multicentre study by the Adrenal Tumours Study Group. Endocr Connect 6:935\u2013942. https:\/\/doi.org\/10.1530\/EC-17-0295","journal-title":"Endocr Connect"},{"key":"2731_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1590\/s1516-44462004000100012","volume":"26","author":"SC Bahls","year":"2004","unstructured":"Bahls SC, de Carvalho GA (2004) The relation between thyroid function and depression: a review. Rev Bras Psiquiatria 26:40\u201348. https:\/\/doi.org\/10.1590\/s1516-44462004000100012","journal-title":"Rev Bras Psiquiatria"},{"key":"2731_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1159\/000442985","volume":"103","author":"JW Buning","year":"2016","unstructured":"Buning JW, Brummelman P, Koerts J et al (2016) Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial. Neuroendocrinology 103:771\u2013778. https:\/\/doi.org\/10.1159\/000442985","journal-title":"Neuroendocrinology"},{"key":"2731_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2018.00037","volume":"10","author":"X Liu","year":"2018","unstructured":"Liu X, Chen W, Tu Y et al (2018) The abnormal functional connectivity between the hypothalamus and the temporal gyrus underlying depression in Alzheimer\u2019s disease patients. Front Aging Neurosci 10:1\u201311. https:\/\/doi.org\/10.3389\/fnagi.2018.00037","journal-title":"Front Aging Neurosci"},{"key":"2731_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0301-0511(01)00090-4","volume":"57","author":"D Riemann","year":"2001","unstructured":"Riemann D, Berger M, Voderholzer U (2001) Sleep and depression - results from psychobiological studies: an overview. Biol Psychol 57:67\u2013103. https:\/\/doi.org\/10.1016\/S0301-0511(01)00090-4","journal-title":"Biol Psychol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02731-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-021-02731-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02731-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T02:04:21Z","timestamp":1658628261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-021-02731-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1007\/s11845-021-02731-y","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Luebeck (05\/21\/2017, file number: 16\u2013180).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}